LinkedIn Profile

Access Sangamo BioSciences historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:sgmo 50127 Apr 21st, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 356.00 Open Apr 21st, 2024 12:06AM Apr 21st, 2024 12:06AM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 20th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 356.00 Open Apr 20th, 2024 12:03AM Apr 20th, 2024 05:37PM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 19th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 362.00 Open Apr 19th, 2024 04:38AM Apr 19th, 2024 04:38AM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 18th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 362.00 Open Apr 18th, 2024 12:43AM Apr 18th, 2024 06:58PM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 17th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 364.00 Open Apr 17th, 2024 12:01AM Apr 17th, 2024 03:24PM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 16th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 364.00 Open Apr 15th, 2024 11:57PM Apr 16th, 2024 11:40AM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 15th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 364.00 Open Apr 14th, 2024 11:52PM Apr 15th, 2024 05:21PM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 14th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 364.00 Open Apr 13th, 2024 11:41PM Apr 13th, 2024 11:41PM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 13th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 364.00 Open Apr 12th, 2024 11:33PM Apr 13th, 2024 12:06PM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology
nasdaq:sgmo 50127 Apr 12th, 2024 12:00AM Sangamo Therapeutics, Inc. 39K 367.00 Open Apr 11th, 2024 11:39PM Apr 12th, 2024 09:02AM For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Open Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, Cell Therapy, Tauopathies, and Immunology Open 7000 Marina Blvd Brisbane California US 94005 Sangamo BioSciences Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.